Related references
Note: Only part of the references are listed.Testosterone replacement therapy for male hypogonadism: Part III. Pharmacologic and clinical profiles, monitoring, safety issues, and potential future agents
A. Seftel
INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH (2007)
An effect on the subjective sexual response in premenopausal women with sexual arousal disorder by bremelanotide (PT-141), a melanocortin receptor agonist
Lisa E. Diamond et al.
JOURNAL OF SEXUAL MEDICINE (2006)
Burden of phase-specific sexual dysfunction with SSRIs
A Clayton et al.
JOURNAL OF AFFECTIVE DISORDERS (2006)
Use of bupropion in combination with serotonin reuptake inhibitors
S Zisook et al.
BIOLOGICAL PSYCHIATRY (2006)
Andropause: A quality-of-life issue in older males
Matthew T. Haren et al.
MEDICAL CLINICS OF NORTH AMERICA (2006)
Central nervous system agents in the treatment of erectile dysfunction
M Kendirci et al.
UROLOGIC CLINICS OF NORTH AMERICA (2005)
Effects of testosterone on sexual function in men: results of a meta-analysis
AM Isidori et al.
CLINICAL ENDOCRINOLOGY (2005)
Co-administration of low doses of intranasal PT-141, a melanocortin receptor agonist, and sildenafil to men with erectile dysfunction results in an enhanced erectile response
LE Diamond et al.
UROLOGY (2005)
Reappraisal of the risk of iodine-induced hyperthyroidism: An epidemiological population survey
F Azizi et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2005)
The endocrinology of sexual arousal
J Bancroft
JOURNAL OF ENDOCRINOLOGY (2005)
Effect of a single dose of levodopa on sexual response in men and women
S Both et al.
NEUROPSYCHOPHARMACOLOGY (2005)
Evaluation of the safety, pharmacokinetics and pharmacodynamic effects of subcutaneously administered PT-141, a melanocortin receptor agonist, in healthy male subjects and in patients with an inadequate response to Viagra®
RC Rosen et al.
INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH (2004)
Medical progress - Risks of testosterone-replacement therapy and recommendations for monitoring
EL Rhoden et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Efficacy of apomorphine and sildenafil in men with nonarteriogenic erectile dysfunction. A comparative crossover study
P Perimenis et al.
ANDROLOGIA (2004)
A comparative, crossover study of the efficacy and safety of sildenafil and apomorphine in men with evidence of arteriogenic erectile dysfunction
P Perimenis et al.
INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH (2004)
Double-blind, placebo-controlled evaluation of the safety, pharmacokinetic properties and pharmacodynamic effects of intranasal PT-141, a melanocortin receptor agonist, in healthy males and patients with mild-to-moderate erectile dysfunction
LE Diamond et al.
INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH (2004)
Long-term effect of sildenafil citrate on erectile dysfunction after radical prostatectomy: 3-year follow-up
R Raina et al.
UROLOGY (2003)
Changes in human in vivo serotonin and dopamine transporter availabilities during chronic antidepressant administration
A Kugaya et al.
NEUROPSYCHOPHARMACOLOGY (2003)
A role for the melanocortin 4 receptor in sexual function
LHT Van der Ploeg et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Prevalence of sexual dysfunction among newer antidepressants
AH Clayton et al.
JOURNAL OF CLINICAL PSYCHIATRY (2002)
Efficacy of apomorphine SL in erectile dysfunction
VG Mirone et al.
BJU INTERNATIONAL (2001)
Sustained-release bupropion for selective serotonin reuptake inhibitor-induced sexual dysfunction: A randomized, double-blind, placebo-controlled, parallel-group study
PS Masand et al.
AMERICAN JOURNAL OF PSYCHIATRY (2001)
Double-blind, crossover comparison of 3 mg apomorphine SL with placebo and with 4 mg apomorphine SL in male erectile dysfunction
E Dula et al.
EUROPEAN UROLOGY (2001)
Erectile dysfunction: from biochemical pharmacology to advances in medical therapy
M Maggi et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2000)
Share Paper
